Alyeska Investment Group’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-500
| Closed | -$270K | – | 498 |
|
|
2018
Q2 | $270K | Buy |
500
+16
| +3% | +$8.64K | ﹤0.01% | 397 |
|
|
2018
Q1 | $223K | Sell |
484
-4
| -0.8% | -$1.84K | ﹤0.01% | 395 |
|
|
2017
Q4 | $327K | Hold |
488
| – | – | ﹤0.01% | 378 |
|
|
2017
Q3 | $308K | Buy |
488
+8
| +2% | +$5.05K | ﹤0.01% | 417 |
|
|
2017
Q2 | $230K | Sell |
480
-14
| -3% | -$6.71K | ﹤0.01% | 416 |
|
|
2017
Q1 | $371K | Sell |
494
-6
| -1% | -$4.51K | ﹤0.01% | 440 |
|
|
2016
Q4 | $490K | Buy |
+500
| New | +$490K | ﹤0.01% | 428 |
|